Therapeutic testing in murine models of bacterial thigh, lung and peritonitis infections a-32
Ended Awarded Last action
- Contract number
- 75N93019F00131
- Awardee
-
Pharmacology Discovery Services Taiwan, LTD. UEI MXP1NVQ8C1J8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $652,380
Award facts
- Opportunity
-
- NIHAI2016059 Solicitation number
- Contract value 55% obligated
-
- $652,380.00 Current, with exercised options
- $1,187,770.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Taiwan
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$1,750 | |
| Exercise an Option | $52,710 | |
| Original award | $601,420 |
About this award
The National Institute of Allergy and Infectious Diseases issued a $1,187,770 delivery order to Pharmacology Discovery Services Taiwan, LTD. on July 1, 2019, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ for therapeutic testing in murine models of bacterial thigh, lung, and peritonitis infections.
The parent IDIQ supports preclinical infectious disease research by providing animal and animal replacement models for screening and evaluating medical countermeasures including therapeutics, vaccines, and diagnostics. Place of performance is Taiwan. The order was issued on a firm fixed price basis with an ultimate completion date of June 30, 2020.
In FY2020, Pharmacology Discovery Services Taiwan invoiced $652 thousand in government-paid labor and self-performed all reported hours with no subcontractors.
Quick answers
Who was awarded contract 75N93019F00131?
75N93019F00131 was awarded to Pharmacology Discovery Services Taiwan, LTD. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2019.
How much is contract 75N93019F00131 worth?
The government has obligated $652,380 on 75N93019F00131. Its potential value, with all options, is $1,187,770.
Is contract 75N93019F00131 an order under another contract?
Yes. 75N93019F00131 is a delivery order under HHSN272201700020I, an indefinite delivery contract, on NIAID Preclinical Models of Infectious Diseases 2017-2024.
Was contract 75N93019F00131 competed?
The extent of competition for 75N93019F00131 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award